Furthermore, 54 DEGs were found to be implicated in various progression stages of lung adenocarcinoma, while 41 and 46 DEGs were found to be different according to the EGFR or KRAS mutation status of the tumor, respectively (Table S10). This evidence concerns the gene KRAS and lung adenocarcinoma.